The interaction of hepatic lipid and glucose metabolism in liver diseases (Q26827770)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173168%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

The interaction of hepatic lipid and glucose metabolism in liver diseases (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173168%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173168%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Guido Gerken

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173168%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ali Canbay

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173168%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

5

Michael Trauner

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173168%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

4

Gökhan S Hotamisligil

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173168%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Rebekka A Hannivoort

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173168%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

1 reference

13 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173168%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

published in

Journal of Hepatology

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173168%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

56

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173168%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173168%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

952-964

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173168%20AND%20SRC:MED&resulttype=core&format=json

Relationship between insulin resistance, inflammation and liver cell apoptosis in patients with severe obesity.

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Bile acids are "homeotrophic" sensors of the functional hepatic capacity and regulate adaptive growth during liver regeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Macroautophagy and chaperone-mediated autophagy are required for hepatocyte resistance to oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Cyclooxygenase inhibition Up-regulates liver carnitine palmitoyltransferase 1A expression and improves fatty liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Adiponectin activation of AMPK disrupts leptin-mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS-3)

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Identification of caveolin-1 as a fatty acid binding protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

The human fatty acid transport protein-1 (SLC27A1; FATP-1) cDNA and gene: organization, chromosomal localization, and expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFkappaB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

The MAP1-LC3 conjugation system is involved in lipid droplet formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Human fat cell lipolysis: biochemistry, regulation and clinical role

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Born to run; the story of the PEPCK-Cmus mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Identification of a physiologically relevant endogenous ligand for PPARalpha in liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Endoplasmic reticulum stress and the inflammatory basis of metabolic disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Coupling mitochondrial dysfunction to endoplasmic reticulum stress response: a molecular mechanism leading to hepatic insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Non-alcoholic steatohepatitis and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKCλ/ζ

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

mTOR regulation of autophagy

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Autophagy in liver diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Proteolytic and lipolytic responses to starvation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Apoptosis in HepG2 cells exposed to high glucose

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Lipid-induced insulin resistance: unravelling the mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Enzymes of triacylglycerol synthesis and their regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

The role of the lipogenic pathway in the development of hepatic steatosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Adiponectin deficiency impairs liver regeneration through attenuating STAT3 phosphorylation in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Inflammation and metabolic disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Autophagy regulates lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Glucokinase and molecular aspects of liver glycogen metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Pivotal role of mTOR signaling in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Abnormalities of lipid metabolism in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Novel Insights into the Pathophysiology of Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Carbohydrate metabolism and the liver: actual aspects from physiology and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Temporal pattern of de novo lipogenesis in the postprandial state in healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Regulation of the fatty acid synthase promoter by insulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Free fatty acids and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Liver lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Central role of mitochondria in metabolic regulation of liver pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Lipotoxicity: why do saturated fatty acids cause and monounsaturates protect against it?

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Roles of GSK3 in metabolic shift toward abnormal anabolism in cell senescence

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Caveolin-1 is essential for liver regeneration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Adiponectin and its receptors in non-alcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Autophagy in health and disease. 2. Regulation of lipid metabolism and storage by autophagy: pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

GLUT2 mutations, translocation, and receptor function in diet sugar managing

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Rapid translocation of hepatic glucokinase in response to intraduodenal glucose infusion and changes in plasma glucose and insulin in conscious rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Obesity affects the liver - the link between adipocytes and hepatocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Phosphoenolpyruvate carboxykinase and the critical role of cataplerosis in the control of hepatic metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Bile acids regulate hepatic gluconeogenic genes and farnesoid X receptor via G(alpha)i-protein-coupled receptors and the AKT pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Lipoprotein lipase: genetics, lipid uptake, and regulation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Regulation of carbohydrate metabolism by the farnesoid X receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

GLUT1 as a therapeutic target in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

PPARalpha: energy combustion, hypolipidemia, inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Glycogen and its Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Atf4 regulates obesity, glucose homeostasis, and energy expenditure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Selective reversible inhibition of liver carnitine palmitoyl-transferase 1 by teglicar reduces gluconeogenesis and improves glucose homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene (GCK-MODY).

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

Mitochondrial aspartate aminotransferase expressed on the surface of 3T3-L1 adipocytes mediates saturable fatty acid uptake

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2011.08.025

7 January 2021

10.1016/J.JHEP.2011.08.025

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173168%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017